The Discounted Cash Flow (DCF) valuation of Kukjeon Pharmaceutical Co Ltd (307750.KQ) is 2,637.80 KRW. With the latest stock price at 4,680.00 KRW, the upside of Kukjeon Pharmaceutical Co Ltd based on DCF is -43.6%.
Based on the latest price of 4,680.00 KRW and our DCF valuation, Kukjeon Pharmaceutical Co Ltd (307750.KQ) is a sell. selling 307750.KQ stocks now will result in a potential gain of 43.6%.
Range | Selected | |
WACC / Discount Rate | 6.8% - 9.2% | 8.0% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | 1,546.77 - 6,293.10 | 2,637.80 |
Upside | -66.9% - 34.5% | -43.6% |